Disorders of Water Metabolism

Comprehensive Clinical Nephrology: Fourth Edition

Volumn , Issue , 2010, Pages 100-117

  Parikh, Chirag ^a   Berl, Tomas ^b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861513389     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05876-6.00008-3     Document Type: Chapter

References (46)

1. Verbalis J, Berl T Disorders of water balance. The Kidney 2008, 459-504. WB Saunders, Philadelphia. 8th ed. B.M. Brenner (Ed.).
2. Narins RG, Krishna GC Disorders of water balance. Internal Medicine 1987, 794. Little, Brown, Boston. J.H. Stein (Ed.).
3. Bichet D Nephrogenic and central diabetes insipidus. Diseases of the Kidney and Urinary Tract 2007, Vol 3:2249-2269. Lippincott Williams & Wilkins, Philadelphia. 8th ed.
4. Nielsen S, Frøkiaer J, Marples D, et al. Aquaporins in the kidney: From molecules to medicine. Physiol Rev 2002, 82:205-244.
5. Halterman R, Berl T Therapy of dysnatremic disorders. Therapy in Nephrology and Hypertension 1999, 257-269. WB Saunders, Philadelphia. H. Brady, C. Wilcox (Eds.).
6. Nguyen MK, Ornekian V, Butch AW, et al. A new method for determining plasma water content: Application in pseudohyponatremia. Am J Physiol 2007, 292:F1652-F1656.
7. Cogan M Normal water homeostasis. Fluid and Electrolytes 1991, 98-106. Lange, Norwalk: CT. M. Cogan (Ed.).
8. Sterns RH, Silver SM Cerebral salt wasting versus SIADH: What difference?. J Am Soc Nephrol 2008, 19:194-196.
9. Neilsen S, Schrier R Diseases of the Kidney and Urinary Tract 2007, Lippincott Williams & Wilkins, Philadelphia. 8th ed.
10. Morita S, Inokuchi S, Yamamoto R, et al. Risk factors for rhabdomyolysis in self-induced water intoxication (SIWI) patients. J Emerg Med 2008 Apr 23, [Epub ahead of print].
11. Steele A, Gowrishankar M, Abrahamson S, et al. Postoperative hyponatremia despite near-isotonic saline infusion: A phenomenon of desalination. Ann Intern Med 1997, 126:20-25.
12. Almond CS, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Boston Marathon. N Engl J Med 2005, 352:1550-1556.
13. Hew-Butler T, Jordaan E, Stuempfle KJ, et al. Osmotic and nonosmotic regulation of arginine vasopressin during prolonged endurance exercise. J Clin Endocrinol Metab 2008, 93:2072-2078.
14. Liamis G, Milionis H, Elisaf M A review of drug-induced hyponatremia. Am J Kidney Dis 2008, 52:144-153.
15. Berl T, Schrier R Disorders of water metabolism. Renal and Electrolyte Disorders 2010, 1-44. Lippincott Williams & Wilkins, Philadelphia. 6th ed. R. Schrier (Ed.).
16. Palmer BF, Sterns RH Fluid, electrolytes, and acid-base disturbances. NephSAP 2009, 8:70-167.
17. Daphnis E, Stylianou K, Alexandrakis M, et al. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy. Nephron Clin Pract 2007, 106:c143-148.
18. Miller M Hyponatremia: Age related risk factors and therapy decisions. Geriatrics 1998, 53:32-33. 37-38, 41-42.
19. Ellison DH, Berl T Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007, 356:2064-2072.
20. Decaux G, Vandergheynst F, Bouko Y, et al. Nephrogenic syndrome of inappropriate antidiuresis in adults: High phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 2007, 18:606-612.
21. Verbalis J The syndrome of inappropriate antidiuretic hormone secretion and other hypo-osmolar disorders. Diseases of the Kidney and Urinary Tract 2007, Lippincott Williams & Wilkins, Philadelphia. 8th ed. R. Schrier (Ed.).
22. Papadopoulos MC, Verkman AS Aquaporin-4 and brain edema. Pediatr Nephrol 2007, 22:778-784.
23. Yang B, Zador Z, Verkman AS Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J Biol Chem 2008, 283:15280-15286.
24. Verbalis J Diseases of the Kidney and Urinary Tract 2007, Lippincott Williams & Wilkins, Philadelphia. 8th ed. R. Schrier (Ed.).
25. Thurman J, Berl T Therapy of dysnatremic disorders. Therapy in Nephrology and Hypertension 2008, 337-352. WB Saunders, Philadelphia. 3rd ed. C. Wilcox (Ed.).
26. Hew-Butler T, Ayus JC, Kipps C, et al. Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med 2008, 18:111-121.
27. Mohmand HK, Issa D, Ahmad Z, et al. Hypertonic saline for hyponatremia: Risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2007, 2:1110-1117.
28. Perianayagam A, Sterns RH, Silver SM, et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 2008, 3:331-336.
29. Gankam Kengne F, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 2008, 101:583-588.
30. Furst H, Hallows KR, Post J, et al. The urine/plasma electrolyte ratio: A predictive guide to water restriction. Am J Med Sci 2000, 319:240-244.
31. Berl T Impact of solute intake on urine flow and water excretion. J Am Soc Nephrol 2008, 6:1076-1078.
32. 2-receptor antagonist, for hyponatremia. N Engl J Med 2006, 355:2099-2112.
33. Zeltser D, Rosansky S, van Rensburg H, et al. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 2007, 27:447-457.
34. Berl T, Schrier RW Vasopressin antagonist in physiology and disease. Textbook of Nephro-Endocrinology 2009, 249-260. Academic Press, San Diego. A. Singh, G. Williams (Eds.).
35. Rossi J, Bayram M, Udelson JE, et al. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: Insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care 2007, 9:82-86.
36. 2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology 2008, 48:204-213.
37. Koenig MA, Bryan M, Lewin JL, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008, 70:1023-1029.
38. Maghnie M Diabetes insipidus. Horm Res 2003, 59:42-54.
39. Phillips JA Dominant-negative diabetes insipidus and other endocrinopathies. J Clin Invest 2003, 112:1641-1643.
40. Smith CJ, Crock PA, King BR, et al. Phenotype-genotype correlations in a series of Wolfram syndrome families. Diabetes Care 2004, 27:2003-2009.
41. Mavrakis AN, Tritos NA Diabetes insipidus with deficient thirst: Report of a patient and review of the literature. Am J Kidney Dis 2008, 51:851-859.
42. Lanese D, Teitelbaum I Hypernatremia. The Principles and Practice of Nephrology 1995, 893-898. Mosby, St. Louis. 2nd ed. H.R. Jacobson, G.E. Striker, S. Klahr (Eds.).
43. Rao R, Zhang MZ, Zhao M, et al. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2 dependent polyuria. Am J Physiol Renal Physiol 2005, 288:F642-F649.
44. Bedford JJ, Weggery S, Ellis G, et al. Lithium-induced nephrogenic diabetes insipidus: Renal effects of amiloride. Clin J Am Soc Nephrol 2008, 3:1324-1331.
45. Nielsen J, Kwon TH, Frøkiaer J, et al. Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD. Am J Physiol Renal Physiol 2006, 290:F1222-F1233.
46. Polderman KH, Schreuder WO, van Schijndel RJ, et al. Hypernatremia in the intensive care unit: An indicator of quality of care?. Crit Care Med 1999, 27:1105-1108.